Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

One arm is more likely that the other to hurt during a heart attack. It's the arm that shares nerves that branch from the ...

Women with type 2 diabetes are nearly twice as likely as men to have undetected heart damage, according to a new study by ...

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of breath, fatigue, and swelling. Recognizing these signs early is crucial for ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...